BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1717985)

  • 1. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
    Giebel LB; Spritz RA
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8696-9. PubMed ID: 1717985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Giebel LB; Holmes SA
    Am J Hum Genet; 1992 Feb; 50(2):261-9. PubMed ID: 1370874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.
    Spritz RA; Holmes SA; Ramesar R; Greenberg J; Curtis D; Beighton P
    Am J Hum Genet; 1992 Nov; 51(5):1058-65. PubMed ID: 1384325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Holmes SA; Itin P; Küster W
    J Invest Dermatol; 1993 Jul; 101(1):22-5. PubMed ID: 7687267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.
    Fleischman RA
    J Clin Invest; 1992 Jun; 89(6):1713-7. PubMed ID: 1376329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism.
    Ezoe K; Holmes SA; Ho L; Bennett CP; Bolognia JL; Brueton L; Burn J; Falabella R; Gatto EM; Ishii N
    Am J Hum Genet; 1995 Jan; 56(1):58-66. PubMed ID: 7529964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human piebaldism: relationship between phenotype and site of kit gene mutation.
    Ward KA; Moss C; Sanders DS
    Br J Dermatol; 1995 Jun; 132(6):929-35. PubMed ID: 7544995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the c-kit protooncogene in the human developmental defect piebald trait.
    Fleischman RA; Saltman DL; Stastny V; Zneimer S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10885-9. PubMed ID: 1720553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of human piebaldism.
    Spritz RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):137S-140S. PubMed ID: 7525736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the c-kit codon 584 Phe----Leu substitution demonstrated in human piebaldism.
    Fleischman RA
    Am J Hum Genet; 1992 Sep; 51(3):677-8. PubMed ID: 1379775
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel KIT missense mutation in one Chinese family with piebaldism.
    Yin XY; Ren YQ; Yang S; Xu SX; Zhou FS; Du WH; Lin D; Wang PG; Zhang SM; Zhang XJ
    Arch Dermatol Res; 2009 Jun; 301(5):387-9. PubMed ID: 19430803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent deletion in the KIT (mast/stem cell growth factor receptor) proto-oncogene is a frequent cause of human piebaldism.
    Spritz RA; Holmes SA; Berg SZ; Nordlund JJ; Fukai K
    Hum Mol Genet; 1993 Sep; 2(9):1499-500. PubMed ID: 7694728
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymerase chain reaction detection of a novel human KIT (mast/stem cell growth factor receptor) gene polymorphism by single-strand conformation polymorphism analysis or by SmaI or BstNI cleavage.
    Spritz RA; Holmes SA
    Hum Genet; 1993 Sep; 92(2):208-9. PubMed ID: 7690341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice transgenic for Kit(V620A): recapitulation of piebaldism but not progressive depigmentation seen in humans with this mutation.
    Tosaki H; Kunisada T; Motohashi T; Aoki H; Yoshida H; Kitajima Y
    J Invest Dermatol; 2006 May; 126(5):1111-8. PubMed ID: 16456533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of a novel KIT mutation in a Chinese family affected with piebaldism].
    Wang R; Shu S; Zhang Y; Luo W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):637-40. PubMed ID: 27577211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the KIT and PDGFRA genes in a patient with piebaldism.
    Spritz RA; Droetto S; Fukushima Y
    Am J Med Genet; 1992 Nov; 44(4):492-5. PubMed ID: 1279971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel KIT mutation results in piebaldism with progressive depigmentation.
    Richards KA; Fukai K; Oiso N; Paller AS
    J Am Acad Dermatol; 2001 Feb; 44(2):288-92. PubMed ID: 11174389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A novel KIT gene mutation results in piebaldism].
    Deng WP; Lu C; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):545-7. PubMed ID: 16220461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel KIT gene mutation from a family with piebaldism in the southern part of China].
    Deng WP; Huang YS; Lu C; Lan W; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):668-70. PubMed ID: 16331568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of a c-kitW42 minigene in transgenic mice: recapitulation of W phenotypes and evidence for c-kit function in melanoblast progenitors.
    Ray P; Higgins KM; Tan JC; Chu TY; Yee NS; Nguyen H; Lacy E; Besmer P
    Genes Dev; 1991 Dec; 5(12A):2265-73. PubMed ID: 1721031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.